The short answer
GLP-1 drugs like Ozempic and Wegovy do not directly damage your nerves. In rare cases, though, the nausea and vomiting they can cause lead to such poor nutrition that your nerves run short on the B vitamins they need to work, and that shortage can injure them. The damage is often reversible when it is caught early and the missing vitamins are replaced. If you feel new numbness, tingling or weakness on a GLP-1, do not wait it out.
A GLP-1 drug is meant to quiet your appetite, not touch your nerves. So a case published in 2026 is worth your attention. A woman on semaglutide lost the use of her legs, and the cause was not the drug attacking her nervous system. It was a shortage of the vitamins her nerves depend on, driven by months of vomiting she could not shake.
What the 2026 case report found
Doctors described the case in the journal Case Reports in Neurology in June 2026. A 65-year-old woman with type 2 diabetes and obesity started semaglutide and, over about three months, developed persistent nausea, vomiting and abdominal pain. She ate very little and lost roughly 120 pounds.
Then her nervous system began to fail. She arrived at the hospital with profound weakness, barely able to move her legs, with absent reflexes, numbness in her limbs, drooping facial muscles, and trouble swallowing and speaking. A nerve study (an EMG) showed that the sensory signals in her arms and legs were diffusely absent, a pattern the neurologists called a severe sensory neuronopathy. In plain terms, her nerves were badly damaged.
Her bloodwork pointed straight at the cause. Her thiamine (vitamin B1) was 25 nmol/L against a normal range of 70 to 180. Her vitamin B12 sat at 203 pg/mL, below the normal floor of 213. Her folate was below range too. These are the exact vitamins nerves rely on, and all three were low at once.
The treatment was not a drug for the nerves. It was the missing vitamins. She received intravenous thiamine, 500 mg three times a day for three days and then a daily dose, along with B12 and folate. Within five days her thinking cleared and her strength returned, with leg power climbing from barely any movement to nearly normal. Her swallowing recovered over about a week. She left the hospital with a partial recovery, on oral vitamin replacement, and her semaglutide was stopped.
This is a single case, not a study of thousands, so it cannot tell you how often this happens. What it does show, in sharp detail, is a chain of events that is preventable.
How a weight-loss drug ends up starving your nerves
The authors are careful on this point, and so should you be. They state that semaglutide is not a direct cause of vitamin deficiency. The drug does not poison nerves. The damage runs through an indirect path, and every link in that path is a GLP-1 side effect taken to an extreme.
Here is the chain. GLP-1 drugs slow the stomach and blunt appetite, which is how they work. In most people that means smaller meals. In a few, it means weeks of nausea and vomiting and almost no food. The B vitamins are water-soluble, so your body keeps only a small reserve and burns through it quickly. Thiamine stores, for example, can run dry in two to three weeks without enough coming in. Once the tank is empty, nerves lose the fuel they need to send signals, and they start to break down.
This is the peripheral-nerve version of a problem Shield has written about before in the brain. When the same vitamin B1 shortage strikes the brain instead of the limbs, it is called Wernicke encephalopathy, which brings confusion, vision changes and an unsteady gait. If you want the brain side of this story, see our piece on Wernicke encephalopathy and the vitamin B1 risk. Both come from the same root: not the drug itself, but the malnutrition that extreme GI side effects can cause.
The vitamins your nerves run on
A 2025 review in Advances in Nutrition, which mapped the nutritional fallout of these medications, listed the micronutrients worth watching during rapid weight loss. Thiamine (vitamin B1), vitamin B12 and folate are all on it, and all three are central to nerve health.
- Thiamine (vitamin B1) helps nerves produce energy. It is the first to run out because the body stores so little, and it is the one most often behind sudden nutritional nerve damage.
- Vitamin B12 maintains the myelin sheath that insulates nerves. A long shortage can cause numbness, tingling and balance problems that become permanent if ignored.
- Folate works alongside B12 in nerve maintenance, and the two often fall together when intake collapses.
How common is the underlying intake problem? The same review found that GLP-1 drugs cut food intake by 16 to 39 percent in recent studies, with nausea reported by 25 to 44 percent of users. Most people who eat less do not end up with nerve damage. But in older case series of this kind of acute nutritional neuropathy, drawn from people with severe malnutrition for any reason, thiamine was deficient in about 85 percent, vitamin B6 in 77 percent and folate in 50 percent. When intake crashes far enough, the B vitamins go down together.
Warning signs you should not ignore
Most GLP-1 side effects are uncomfortable but not dangerous. Nerve symptoms are different, because the window to reverse them matters. Get medical advice promptly if you notice any of these, especially after a stretch of heavy vomiting or very low eating.
- New or spreading numbness or tingling in the hands or feet.
- Muscle weakness, or legs that feel heavy or give out.
- An unsteady, off-balance walk.
- Trouble swallowing, slurred speech or new facial weakness.
- Confusion, double vision or memory problems, which can signal the brain form and need emergency care.
One caution if you have diabetes. Many people with diabetes already have some numbness from diabetic neuropathy, so it is easy to brush off a new change as more of the same. Do not. A fresh or worsening symptom, particularly during a period of poor eating, deserves a look rather than an assumption.
How to protect your nerves on a GLP-1
The reassuring part of this story is how avoidable it is. The danger did not come from a normal course of treatment. It came from months of uncontrolled vomiting and near-starvation that went unaddressed. A few habits keep you well clear of that edge.
- Do not push through weeks of vomiting. Persistent nausea or vomiting is a reason to call your clinician, not to tough it out. Anti-nausea medication or a slower dose increase often fixes it.
- Keep eating, even small amounts. Frequent small, protein-forward meals are easier to keep down than large ones and protect both your muscle and your vitamin stores.
- Mind the B vitamins. If your intake has dropped sharply, ask about a B-complex or a daily multivitamin, and about blood tests for thiamine, B12 and folate.
- Treat a sudden symptom as urgent. Numbness, weakness or balance trouble is not something to monitor for a week at home.
Protecting your nutrition while a GLP-1 does its main job is the exact problem GLP-1 Shield is built around. Supplements do not treat nerve damage, and they are no substitute for medical care, but closing a real deficiency before it becomes a crisis is the point. For the bigger picture, our overview of GLP-1 side effects and our monitoring guide for vitamins on GLP-1 are good next reads.
Key takeaways
- GLP-1 drugs do not directly damage nerves; the 2026 case report's authors state semaglutide is not a direct cause of vitamin deficiency.
- In rare cases, prolonged vomiting and very low food intake drain the B vitamins nerves depend on, which can injure them.
- In the reported case, a woman with low thiamine, B12 and folate began recovering within 5 days of vitamin replacement, though recovery was only partial.
- Thiamine (vitamin B1), vitamin B12 and folate are the key nerve vitamins, and the body runs low on them fast when you barely eat.
- New numbness, tingling, weakness or balance trouble on a GLP-1 is a reason to seek care promptly, not to wait it out.
Worried about your own nutrient gaps on GLP-1?
Be among the first to try the scientifically designed GLP-1 Shield supplements.
Frequently asked questions
- Can Ozempic cause nerve damage?
- Not directly. The authors of a 2026 case report state plainly that semaglutide is not a direct cause of vitamin deficiency or nerve damage. The risk is indirect: in rare cases the nausea and vomiting these drugs can cause lead to such poor nutrition that nerves run short on the B vitamins they need, and that shortage can injure them. It is uncommon, and it is often reversible when caught early.
- Can Ozempic cause numbness and tingling?
- New numbness or tingling in the hands or feet on a GLP-1 drug is worth checking, especially if you have had weeks of vomiting or very low food intake. It can signal a B-vitamin shortage affecting the nerves. People with diabetes may already have some numbness from diabetic neuropathy, so a new or worsening change should be reported to your clinician rather than assumed to be the same thing.
- Is nerve damage from a vitamin shortage reversible?
- Often, if it is caught early. In the 2026 case report, a woman with severe nerve damage and low thiamine, B12 and folate began improving within 5 days of vitamin replacement and regained much of her strength. Recovery was partial, not complete, which is why acting early matters. The longer a severe deficiency goes untreated, the more lasting the nerve injury can be.
- Which vitamins protect your nerves on a GLP-1?
- The B vitamins do most of the work for nerve health, especially thiamine (vitamin B1), vitamin B12 and folate. These are water-soluble, so the body stores little and runs low fast when you eat very little. A 2025 review recommends monitoring B12, folate and thiamine during rapid weight loss. If your intake has dropped sharply, ask your clinician about testing and a B-complex or multivitamin.
Sources
- Cohan CJ, Townley L, Ortega E. Acute nutritional axonal neuropathy in the setting of semaglutide-associated gastrointestinal intolerance: a case report. Case Rep Neurol. 2026;18(1):402-412. https://pmc.ncbi.nlm.nih.gov/articles/PMC13432944/
- Ben-Porat T, Sherf-Dagan S, Côté M, Miner CJ, Buch A. Nutritional challenges of incretin-based obesity management medications: implications for clinical practice. Adv Nutr. 2025;16(11):100522. https://pmc.ncbi.nlm.nih.gov/articles/PMC12550150/